Controversy over new AstraZeneca trial data raises more unwanted vaccine questions


Despite extensive evidence and repeated regulatory assurances that the OxfordAstraZeneca vaccine is safe to use, confidence in the life-saving jab remains at its lowest.

From questions over its efficacy among the elderly, to reports of blood clots in some recipients, the vaccine’s rollout has been repeatedly slowed and hampered outside Britain.

Dr Anthony Fauci, the White House’s chief medical adviser, said the company’s interpretation of the trial results seemed to be “in my mind … an unforced error”.

“I was sort of stunned,” he said on Tuesday morning, by how positive the results were, even compared with previous trial data from the company. “We felt that we could not remain silent.”



Source link

Related posts